p53 mutation is a poor prognostic indicator for survival in patients with hepatocellular carcinoma undergoing surgical tumour ablation

British Journal of Cancer

Volumn 77, Issue 5, 1998, Pages 776-782

  Honda, K ^a   Sbisa E ^b   Tullo, A ^b   Papeo, P A ^c   Saccone, C ^c   Poole, S ^b   Pignatelli, M ^a   Mitry, R R ^a   Ding, S ^a   Isla, A ^a   Davies, A ^a   Habib, N A ^a,d  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b CNR   (Italy)

^c UNIVERSITY OF BARI   (Italy)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Cirrhosis; Hepatitis; Liver carcinoma; Oncosuppressor gene

Indexed keywords

PROTEIN P53;

ADOLESCENT; ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CLINICAL ARTICLE; CODON; DENATURING GRADIENT GEL ELECTROPHORESIS; EXON; GENE INSERTION; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 15144343103     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.126     Document Type: Article

References (32)

1. Abadie V, Lyonnet S, Maurin N, Berthelon M, Caillaud C, Giraud F, Mattei J-F, Rey F and Munnich A (1989) CpG dinucleotides are mutation hot spots in phenylketonuria. Genomics 5: 936-439
2. Adelman R, Saul R L and Ames BN (1988) Oxidative damage to DNA: relation to species metabolic rate and life span. Proc Natl Acad Sci USA 85: 2706-2708
3. Beck JS, Kwitek AE, Cogen PH, Metzger AK, Duyk GM and Sheffield VC (1993) A denaturing gradient gel electrophoresis assay for sensitive detection of p53 mutations. Hum Genet, 91: 25-30
4. Bressac B, Kew M, Wands J and Ozturk M (1991) Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 350: 429-431
5. Buetow KH, Sheffield VC, Zhu M, Zhou T, Shen FM, Hino O, Smith M, McMahon BJ, Lanier AP, London WT, Redekar AG and Govindarajan S (1992) Low frequency of p53 mutations observed in a diverse collection of primary hepatocellular carcinomas. Proc Natl Acad Sci USA 89: 9622-9626
6. Cho Y, Gorina S, Jeffrey PD and Pavletich NP (1994) Crystal structure of a p53 tumour suppressor-DNA complex: understanding tumorigenic mutations. Science 265: 346-355
7. D'Agostini F, Fronza G, Campomenosi P, Izzotti A, Petrilli GI, Abbondandolo A, and De Flora S (1995) Cancer biomarkers in human atherosclerotic lesions: no evidence of p53 involvement. Cancer Epidemiol Biomarkers Prev 4: 111-115
8. Ding S-F, Habib NA, Dooley J, Wood C, Bowles L and Delhanty JDA (1991) Loss of constitutional heterozygosity on chromosome 5q in hepatocellular carcinoma without cirrhosis. Br J Cancer 64: 1083-1087
9. Ding S-F, Carrillo A, Dooley JS, Delhanty JDA, Bowles L, Dalla Serra G, Wood CB and Habib NA (1993a) Multiple allelic losses in sarcomatoid liver carcinoma. Int Hepatol Commun 1: 295-301
10. Ding S-F, Delhanty JDA, Bowles L, Dooley JS, Wood CB and Habib NA (1993b) Infrequent chromosome allele loss in fibrolamellar carcinoma. Br J Cancer 67: 244-246
11. Feitelson MA and Duan LX (1997) Hepatitis B virus X antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma. Am J Pathol 4: 1141-1157
12. Feitelson MA, Zhu M, Duan LX and London WT (1993) Hepatitis B x antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma. Oncogene 8: 1109-1117
13. Habib NA, Ding S-F, El-Masry R, Mitry RR, Honda K, Michail NE, Dalla Serra G, Izzi G, Greco L, Bassyouni M, El-Toukhy M and Abdel-Ghaffar Y (1996) Preliminary report: the short-term effects of direct p53 DNA injection in primary hepatocellular carcinomas. Cancer Detect Prevention 20/2: 103-107
14. Hayashi H, Sugio K, Matsumata T, Adachi E, Takenaka K and Sugimachi K (1995) The clinical significance of p53 gene mutation in hepatocellular carcinomas from Japan. Hepatology 22: 1702-1707
15. Hino O, Shows IB and Rogler CE (1986) Hepatitis B virus integration site in hepatocellular carcinoma at chromosome translocation. Proc Natl Acad Sci USA 83: 8338-8342
16. Hollstein M, Rice K, Greenblatt MS, Soussi T, Fuchs R, Sorlie T, Hovig E, Smith-Sorensen B, Montesano R and Harris CC (1994) Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acid Res 22: 3551-3555
17. Hosono S, Lee C-S, Chou MJ, Yang C-S and Shih C (1991) Infrequent mutation of p53 gene in hepatitis B virus positive primary hepatocellular carcinomas. Oncogene 6: 237-243
18. Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ and Harris CC (1991) Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 350: 427-428
19. Kakizoe S, Kojiro M and Nakashima T (1987) Hepatocellular carcinoma with sarcomatous changes. Clinicopathologic and immunohistochemical studies of 14 autopsy cases. Cancer 59: 310-316
20. Lamb P and Crawford I (1986) Characterization of the human p53 gene. Mol Cell Biol 6: 1379-1385
21. Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, Bigner SH, Davidson N, Baylin S and Devilee (1989) Mutations in the p53 gene occur in diverse human tumour types. Nature 342: 705-708
22. Nishida N, Fukuda Y, Kokuryu H, Toguchida J, Yandell DW, Ikenega M, Imura H and Ishizaki K (1991) Role and mutational heterogeneity of p53 gene in hepatocellular carcinoma. Cancer Res 53: 368-372
23. Nose H, Imazeki F, Ohto M and Omata M (1990) p53 gene mutations and 17p allelic deletions in hepatocellular carcinoma from Japan. Cancer 72: 355-360
24. Robinson W (1994) Molecular events in the pathogenesis of Hepadnavirus-associated hepatocellular carcinoma. Annu Rev Med 45: 297-323
25. Sambrook J, Fritsch EF and Maniatis T (1989) Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York
26. Serra A, Gaidiano GL, Revello D, Guerrasio A, Ballerini P, Dalla Favera R and Saglio G (1992) A new Taq1 polymorphism in the p53 gene. Nucleic Acid Res, 20: 928
27. Shich YS, Nguyen C, Vocal MV and Chu HW (1993) Tumor-suppressor p53 gene in hepatitis C and B virus-associated in hepatocellular carcinoma. Int J Cancer 54: 558-562
28. Slagle B, Zhou YZ and Butel JS (1991) Hepatitis B virus integration event in human chromosome 17p near the p53 gene identifies the region of the chromosome commonly deleted in virus-positive hepatocellular carcinomas. Cancer Res 51: 49-54
29. Teramoto T, Satonaka K, Kitazawa S, Fujimori T, Hayashi K and Maeda S (1994) p53 gene abnormalities are closely related to hepatoviral infections and occur at a late stage of hepatocarcinogenesis. Cancer Res 54: 231-235
30. Thukral SK, Blain GC, Chang KKH and Fields S (1994) Distinct residues of human p53 implicated in binding to DNA, simian virus 40 large T antigen, 53BPI and 53B22. Mol Cell Biol 14: 8315-8321
31. Vecchio FM, Fabiano A, Ghirlande G, Manna R and Massi G (1984) Fibrolamellar carcinoma of the liver: the malignant counterpart of focal nodular hyperplasia with oncocytic changes. Am J Clin Pathol 81: 521-526
32. Weghorst CM, Buzard GS, Calveri RJ, Hula JE and Rice MJ (1995) Cloning and sequence of a processed p53 pseudogene from rat: a potential source of false 'mutations' in PCR fragments of tumor DNA. Gene 166: 317-322